Sun Pharmaceutical Industries Limited
SUNPHARMA
Classifica tra le azioni
#526
Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical... Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical enterprise, is dedicated to the research, development, production, and marketing of both proprietary and unbranded medicinal formulations, alongside active pharmaceutical ingredients (APIs), for distribution across India and international markets. Its extensive product range encompasses treatments for numerous therapeutic fields, including central nervous system disorders, dermatological conditions, cardiovascular diseases, oncology, ophthalmic care, neuropsychiatry, gastrointestinal issues, infectious diseases, diabetes management, pain relief, nutritional supplements, respiratory ailments, gynaecology, urology, orthopaedics, nephrology, and dental health, among others. The company additionally provides APIs crucial for the creation of anti-cancer drugs, peptides, steroids, sex hormones, and controlled substances. Its generic medications are available in various forms, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquid preparations. Furthermore, Sun Pharma develops specialized medications and a variety of over-the-counter health products. The company was established in 1983 and operates from its headquarters in Mumbai, India.
Prezzo delle azioni
$19.24
Ultima sincronizzazione: 2026-10-19
Capitalizzazione di mercato
$46.15B
Variazione (1 giorno)
-0.97%
Variazione (1 anno)
0.11%
Paese
IN
Scambia Sun Pharmaceutical Industries Limited (SUNPHARMA)
Categoria
Healthcare
Ricavi di Sun Pharmaceutical Industries Limited (SUNPHARMA)
Ricavi nel Jun 2026 TTM: $6.61B
Secondo gli ultimi rapporti finanziari di Sun Pharmaceutical Industries Limited, i ricavi attuali dell'azienda (TTM) sono pari a $6.61B. Nel 2024, l'azienda ha registrato ricavi di $5.82B un aumento rispetto a i ricavi dell'anno 2023, che erano pari a $5.34B. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Sun Pharmaceutical Industries Limited da 2004 a 2026
Ricavi alla fine di ogni anno
| Anno | Ricavi | Cambia |
|---|---|---|
| 2026 (TTM) | $6.61B | 7.55% |
| 2025 | $6.15B | 5.70% |
| 2024 | $5.82B | 8.91% |
| 2023 | $5.34B | 4.87% |
| 2022 | $5.09B | 11.28% |
| 2021 | $4.58B | 4.98% |
| 2020 | $4.36B | 4.14% |
| 2019 | $4.19B | 3.17% |
| 2018 | $4.06B | -15.97% |
| 2017 | $4.83B | 13.79% |
| 2016 | $4.24B | -3.35% |
| 2015 | $4.39B | 63.63% |
| 2014 | $2.68B | 29.00% |
| 2013 | $2.08B | 31.80% |
| 2012 | $1.58B | 22.91% |
| 2011 | $1.28B | 47.70% |
| 2010 | $869.23M | 3.29% |
| 2009 | $841.54M | 0.33% |
| 2008 | $838.79M | 70.54% |
| 2007 | $491.84M | 33.83% |
| 2006 | $367.50M | 33.92% |
| 2005 | $274.42M | 20.98% |
| 2004 | $226.82M | 0.00% |
Ricavi di aziende simili o concorrenti
| Azienda | Ricavi | Differenza nei ricavi | Il paese |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| - | - |
CN
|
